carteolol has been researched along with metoprolol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T | 1 |
| Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF | 1 |
| Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Nomura, T; Saito, S; Sakurada, T; Suzuki, M; Yamamoto, M; Yoshida, K | 1 |
| Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
| Hirota, M; Ikegami, H; Kumahara, Y; Shima, K; Tahara, Y; Tanaka, A | 1 |
| Hagihara, T; Kishi, Y; Matsumoto, G; Matsuo, H; Naka, K; Nanjo, K; Ohoshi, T; Sanke, T; Sasaki, H; Sowa, R | 1 |
| Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y | 1 |
| Chiba, I; Hiramori, K; Kobayashi, N; Saito, M; Segawa, I; Taniguchi, Y; Ueshima, K | 1 |
| Jia, L; Li, Z; Wu, J; Xiao, X | 1 |
| Chen, YW; Chou, AK | 1 |
1 review(s) available for carteolol and metoprolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
2 trial(s) available for carteolol and metoprolol
| Article | Year |
|---|---|
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol | 1989 |
Effect of carteolol, indenolol and metoprolol on the thyroid hormone of hyperthyroid patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carteolol; Female; Heart Rate; Humans; Hyperthyroidism; Indenes; Male; Metoprolol; Middle Aged; Propanolamines; Thyroid Hormones | 1985 |
10 other study(ies) available for carteolol and metoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cardiomyopathy, Dilated; Carteolol; Drug Evaluation; Male; Metoprolol; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Myocardium; Organ Size; Survival Analysis; Time Factors | 1991 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
Effect of three beta-blockers with different pharmacological properties on metabolic, cardiovascular and hormonal response to insulin-induced hypoglycemia in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; C-Peptide; Carteolol; Glucagon; Growth Hormone; Hemodynamics; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Propranolol; Pulse | 1984 |
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nicardipine; Propanolamines | 1994 |
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carteolol; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Injections, Intraperitoneal; Injections, Spinal; Injections, Subcutaneous; Male; Mecamylamine; Metoprolol; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxidopamine; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Receptors, Nicotinic; Tail; Tremor | 1997 |
A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Cardiomyopathy, Dilated; Carteolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Oxygen; Pulmonary Gas Exchange; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Electrophoresis, Capillary; Equipment Design; Humans; Limit of Detection; Magnetics; Magnetite Nanoparticles; Metoprolol; Norepinephrine; Solid Phase Microextraction; Stereoisomerism | 2019 |
Beta-blocker carteolol and oxprenolol produce cutaneous analgesia in response to needle pinpricks in the rat.
Topics: Acebutolol; Analgesia; Anesthetics, Local; Animals; Bupivacaine; Butoxamine; Carteolol; Dose-Response Relationship, Drug; Epinephrine; Metoprolol; Oxprenolol; Pain; Rats; Rats, Sprague-Dawley | 2023 |